115 related articles for article (PubMed ID: 4038476)
21. High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway.
Basta M; Fries LF; Frank MM
Blood; 1991 Aug; 78(3):700-2. PubMed ID: 1859883
[TBL] [Abstract][Full Text] [Related]
22. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
24. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
Kapil A; Sharma S
J Pharm Pharmacol; 1994 Nov; 46(11):922-3. PubMed ID: 7897600
[TBL] [Abstract][Full Text] [Related]
25. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.
Jaffe CJ; Atkinson JP; Frank MM
J Clin Invest; 1976 Oct; 58(4):942-9. PubMed ID: 965497
[TBL] [Abstract][Full Text] [Related]
26. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
Asghar SS; de Koster A; van der Helm HJ
Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
[TBL] [Abstract][Full Text] [Related]
27. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
[TBL] [Abstract][Full Text] [Related]
28. Identification of alternative pathway serum complement activity in the blood of the American alligator (Alligator mississippiensis).
Merchant ME; Roche CM; Thibodeaux D; Elsey RM
Comp Biochem Physiol B Biochem Mol Biol; 2005 Jul; 141(3):281-8. PubMed ID: 15921941
[TBL] [Abstract][Full Text] [Related]
29. Effect of a streptococcal preparation on the complement system.
Kato H; Yokoe N; Matsumura N; Nishida K; Ikezaki M; Hosokawa K; Hotta T; Takemura S; Yoshikawa T; Kondo M
Jpn J Exp Med; 1979 Oct; 49(5):343-50. PubMed ID: 529490
[TBL] [Abstract][Full Text] [Related]
30. Influence of factor D concentrations on fluid phase C3 activation, lysis of rabbit erythrocytes and solubilization of immune complexes.
Sturfelt G; Sjöholm AG; Truedsson L
Immunol Lett; 1989 Feb; 20(3):231-6. PubMed ID: 2714846
[TBL] [Abstract][Full Text] [Related]
31. Streptavidin-induced lysis of homologous biotinylated erythrocytes. Evidence against the key role of the avidin charge in complement activation via the alternative pathway.
Muzykantov VR; Smirnov MD; Samokhin GP
FEBS Lett; 1991 Mar; 280(1):112-4. PubMed ID: 2009954
[TBL] [Abstract][Full Text] [Related]
32. Studies on the binding of complement factor C3 to the surface of human blood platelets.
Endresen GK; Mellbye OJ
Haemostasis; 1984; 14(3):269-80. PubMed ID: 6381253
[TBL] [Abstract][Full Text] [Related]
33. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
34. NIH conference. Primary biliary cirrhosis and the complement system.
Ann Intern Med; 1979 Jan; 90(1):72-84. PubMed ID: 420467
[TBL] [Abstract][Full Text] [Related]
35. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
Ekdahl KN; Nilsson B
J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
[TBL] [Abstract][Full Text] [Related]
36. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.
Fehr J; Hofmann V; Kappeler U
N Engl J Med; 1982 May; 306(21):1254-8. PubMed ID: 6803159
[TBL] [Abstract][Full Text] [Related]
37. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
Okada H; Okada N
Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
[TBL] [Abstract][Full Text] [Related]
38. Hemolysis of normal human erythrocytes by autologous serum complement.
Kitamura H; Nagano A; Kitano E
Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
[TBL] [Abstract][Full Text] [Related]
39. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes.
Lachmann PJ; Voak D; Oldroyd RG; Downie DM; Bevan PC
Vox Sang; 1983; 45(5):367-72. PubMed ID: 6605620
[TBL] [Abstract][Full Text] [Related]
40. Complement receptors in human renal glomeruli.
Matre R; Tönder O
Scand J Immunol; 1976; 5(4):437-41. PubMed ID: 951580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
